LAPS score for individualized treatment of advanced EGFR-mutated non-small cell lung cancer receiving EGFR-TKIs with or without bevacizumab

BACKGROUND: To establish a risk stratification score to facilitate individualized treatment for patients with advanced epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC). METHODS: We enrolled 160 advanced EGFR-mutated NSCLC who received first-generation EGFR-tyrosine k...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yahua, Du, Bin, Lv, Chengliu, Ji, Xiaohui, Lai, Jinhuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506427/
https://www.ncbi.nlm.nih.gov/pubmed/37713583
http://dx.doi.org/10.1080/07853890.2023.2257227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506427/
https://www.ncbi.nlm.nih.gov/pubmed/37713583
http://dx.doi.org/10.1080/07853890.2023.2257227

Ejemplares similares